Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in AVIDITY BIOSCIENCES INC
BALYASNY ASSET MANAGEMENT L.P. holds 6M shares of RNA (AVIDITY BIOSCIENCES INC), worth $435.7M as of 2025-Q4. This is a new position. RNA represents 0.6% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.
Current Value
$435.7M
Current Shares
6M
Total Value Change
+$435.7M
Total Shares Change
+6M
Other major holders of RNA: VANGUARD GROUP INC, FMR LLC, BlackRock, Inc., UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BNP PARIBAS FINANCIAL MARKETS
New |
| 6M |
- |
| $435.7M |
| 0.6% |
| $72.15 |
61 |
| 2025-Q1 | Exited | 0 | -100.0% | $0 | 0.0% | $31.60 | 0 |
| 2024-Q4 | Decreased | 137,057 | -14.8% | $4M | 0.0% | $29.18 | 0 |
| 2024-Q3 | New | 160,809 | - | $7.4M | 0.0% | $42.33 | 38 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $40.85 | 0 |